UBS reiterated a neutral view on eurozone equities, maintaining a cautious stance amid persistent near-term risks while ...

Mineralys Therapeutics Inc (NASDAQ:MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and chronic kidney ...

NatWest Group PLC (LON:NWG) has emerged as the most likely acquirer for TSB Bank, the U.K. subsidiary of Spanish lender Banco ...

Surgery Partners, Inc. (NASDAQ: SGRY) stock fell 12% after the company announced it has concluded discussions with Bain Capital regarding a potential acquisition.

Investing.com -- UBS Global Research has reiterated a neutral stance on U.K. equities, citing weak earnings growth, currency pressures, and heightened near-term economic uncertainty. Despite a more ...

Immuneering Corporation (NASDAQ:IMRX) stock rose 7% on Monday after the clinical-stage oncology company reported positive survival data from its ongoing Phase 2a trial evaluating atebimetinib in ...